Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT ID: NCT01451671
Last Updated: 2020-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2010-11-30
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Non-invasive Prenatal Test
NCT01451684
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is confirmed via invasive testing to be carrying a fetus with a chromosomal abnormality
* Subject is able to provide informed consent
* Subject is ≥ 18 years of age
Exclusion Criteria
* Subject (mother) has a known aneuploidy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cindy Cisneros
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cindy Cisneros
CRA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tracy Roberts
Role: STUDY_DIRECTOR
Ariosa Diagnostics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Diego
San Diego, California, United States
Norton Healthcare
Louisville, Kentucky, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TD002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.